Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
Clinical trial NCT01090973 · TERMINATED
Trial details
- NCT number
- NCT01090973
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-03-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.